All
Sarclisa-Containing Treatment Regimen Shows ‘Remarkable’ Results for Relapsed Myeloma
May 17th 2022The combination of Sarclisa, Kyprolis and dexamethasone improved progression-free survival in patients with pretreated, relapsed myeloma, and has potential to become a new standard of care, an expert said.
Talzenna-Novel Drug Combo Continues to Be Studied in Patients With Triple-Negative Breast Cancer
May 12th 2022Findings from an early-stage trial assessing Talzenna in combination with a novel drug, known as ZEN-3694, have led the manufacturer to initiate a later-stage study in patients with triple-negative breast cancer.
Educating Patients About Cancer Should Not Be a ‘One-Size-Fits-All’ Approach, Says Expert
May 11th 2022When it comes to learning about their disease, patients with cancer can have different preferences, from wanting to discuss treatments with their providers or read handouts, while others may not want to know much at all.
One Nurse’s Devotion to Cancer Has Healed Many Patients
May 10th 2022“I feel her strength, and because of Lorelei — the way she makes me feel comfortable and confident; the way she cares deeply for me, her other patients and colleagues; and her always professional attitude and manner — I realize that, like other obstacles, I will eventually be able to face this, too,” writes one nurse’s patient in an essay nominating her for CURE®’s 2022 Extraordinary Healer award.